Abbott Laboratories' diabetes care segment recently added new products to its lineup. It should remain one of the company's key growth drivers over the long run. There are other good reasons to ...

Over the past few years, Abbott Laboratories' (NYSE: ABT) business has been a bit of a roller coaster. The pandemic disrupted its medical device business, but it was later able to smooth out those ...

In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a price target of $133.00. The company’s shares ...

The projected fair value for Abbott Laboratories is US$132 based on 2 Stage Free Cash Flow to Equity With US$116 share price, Abbott Laboratories appears to be trading close to its estimated fair ...

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Abbott Laboratories (ABT – Research Report) on September 13 and set a price target of $133.00. The company’s shares closed last ...

Fintel reports that on September 19, 2024, Piper Sandler initiated coverage of Abbott Laboratories (NYSE:ABT) with a Overweight recommendation. As of August 26, 2024, the average one-year price ...

Shares of Abbott Laboratories ABT sank 0.37% to $116.40 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.54% to 5,626.02 ...

Texas Governor Greg Abbott announced that the state is taking an aggressive stand against the violent Venezuelan gang, Tren de Aragua (TdA) and declaring the group a "foreign terrorist organization." ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

Labour MP Diane Abbott has accused the Conservatives of "paying lip service to fighting racism" after it accepted another £5m donation from controversial businessman Frank Hester. The chief ...